OALib Journal期刊
ISSN: 2333-9721
费用:99美元
|
|
|
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential
DOI: 10.1186/s12933-019-0864-7
Alberto Corsini, Alberto J. Lorenzatti, Alberto Zambon, Alexander Tenenbaum, Andrey V. Susekov, André Tartar, Anne Tybj?rg-Hansen, Aruna Pradhan, Brian Tomlinson, B?rge G. Nordestgaard, Carlos Aguilar-Salinas, Carlos I. Ponte-Negretti, Chris J. Packard, Fredrik Karpe, Gerald F. Watts, Henry N. Ginsberg, Hisao Ogawa, Hitoshi Shimano, Jane K. Stock, Jean-Charles Fruchart, Jean-Pierre Després, Jesus Millan Nu?ez-Cortes, Jorge Plutzky, Kausik K. Ray, Khalid Al Rasadi, Koutaro Yokote, Lale S. Tokg?zo?lu, Marat V. Ezhov, Marja-Riitta Taskinen, Masanori Aikawa, Massimiliano Ruscica, Michal Vrablík, Michel Farnier, Michel Krempf, Michel P. Hermans, Patrick Duriez, Paul M. Ridker, Paul Valensi, Peter Libby, Philip J. Barter, Pierre Amarenco, Piyamitr Sritara, Raul D. Santos, Richard Ceska, Robert H. Eckel, Ruth McPherson, Shaukat Sadikot, Shizuya Yamashita, Shun Ishibashi, Soo Lim, Ta-Chen Su, Tatsuhiko Kodama, Walter Wahli, Wolfgang Koenig, ?eljko Reiner
Keywords: Residual cardiovascular risk, Visceral obesity, Diabetes, Atherogenic dyslipidemia, Triglycerides, Remnant cholesterol, Selective peroxisome proliferator-activated receptor alpha modulator, SPPARMalpha, Pemafibrate (K-877), Inflammation, PROMINENT
Abstract:
The online version of this article (10.1186/s12933-019-0864-7) contains supplementary material, which is available to authorized users
Full-Text
comments powered by
|
|
Contact Us
service@oalib.com QQ:3279437679
WhatsApp +8615387084133
|
|